|
Role of Cytokines in Myeloma Pathogenesis
|
5R01CA050947-16
|
$283,743
|
$42,561
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INSTITUTE
|
|
Molecular Studies of Cellular Cytotoxicity
|
Z01 BC 010013
|
$541,603
|
$108,321
|
Anderson, Stephen
|
CCR (NCI)
|
|
THE THERAPY OF AML
|
2P01CA055164-15A1
|
$2,404,845
|
$601,211
|
ANDREEFF, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Adult Leukemia Research Center
|
2P01CA018029-32
|
$5,086,500
|
$5,086,500
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Clinical Cancer Cytogenetics
|
Z01 BC 010694
|
$544,006
|
$272,003
|
Arthur, Diane
|
CCR (NCI)
|
|
Cytogenetic Studies of B-cell Chronic Lymphocytic Leukemia (B-CLL)
|
Z01 SC 010282
|
$68,001
|
$6,800
|
Arthur, Diane
|
CCR (NCI)
|
|
Pathogenesis of Notch Leukemia
|
5R01CA082308-09
|
$433,640
|
$108,410
|
ASTER, JON
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Metabolic Syndrome Following Transplant for Leukemia
|
5R01CA112530-02
|
$420,764
|
$420,764
|
BAKER, KEVIN
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Growth Control in Multiple Myeloma
|
5P01CA055819-13
|
$3,499,541
|
$1,399,816
|
BARLOGIE, BART
|
UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
|
|
Regional Oncology Research Center
|
3P30CA006973-45S1
|
$231,549
|
$23,155
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-45S2
|
$126,362
|
$12,636
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
5P30CA006973-45
|
$7,564,613
|
$756,461
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA042014-20
|
$693,487
|
$6,935
|
Beckerle, Mary
|
UNIVERSITY OF UTAH
|
|
Immunobiology of Hybrid Resistance
|
5R01CA036922-24
|
$312,844
|
$312,844
|
Bennett, Michael
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S1
|
$124,531
|
$2,491
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S3
|
$137,869
|
$2,757
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S4
|
$232,326
|
$4,647
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S5
|
$250,000
|
$5,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-43
|
$11,526,509
|
$230,530
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
For Better and For Worse: Late Effects of Cancer and BMT on Spouse-Caregivers
|
5R03CA126401-02
|
$71,126
|
$71,126
|
Bishop, Michelle
|
UNIVERSITY OF FLORIDA
|
|
Developing Immunoablative Regimens for the Engraftment of Allogeneic HSCT
|
Z01 BC 010698
|
$244,217
|
$170,952
|
Bishop, Michael
|
CCR (NCI)
|
|
Cytotoxic-T-Lymphocyte (CTL) Therapy of AML
|
2R01CA072669-11
|
$298,185
|
$298,185
|
Blazar, Bruce
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Growth Regulation and Therapy of Leukemias and Lymphomas
|
5P01CA092372-05
|
$1,185,331
|
$296,333
|
BONDADA, SUBBARAO
|
UNIVERSITY OF KENTUCKY
|
|
The role of myeloid suppressor cells in tumor-specific tolerance
|
1R01CA124996-01A1
|
$311,600
|
$102,828
|
BORRELLO, IVAN
|
JOHNS HOPKINS UNIVERSITY
|
|
University of Michigan Comprehensive Cancer Center CCOP*
|
3U10CA074648-06S1
|
$14,723
|
$589
|
Brenner, Dean
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Hematopoietic Lineage-restricted Minor Histocompatibility Antigens as GVL Targets
|
1R01CA118880-01A1
|
$259,431
|
$259,431
|
BRICKNER, ANTHONY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
5P30CA016087-27
|
$2,563,433
|
$25,634
|
CARROLL, WILLIAM
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
THERAPY OF CML
|
5P01CA049639-19
|
$3,552,240
|
$1,953,732
|
CHAMPLIN, RICHARD
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Novel Approaches to Stem Cell Transplantation
|
5P01CA047741-15
|
$1,686,422
|
$1,096,174
|
Chao, Nelson
|
DUKE UNIVERSITY
|
|
Hematopoietic Stem Cell Donor Enrollment and Retention in Korean Americans
|
1R03CA130726-01
|
$63,000
|
$63,000
|
CHOE, JOHN
|
UNIVERSITY OF WASHINGTON
|
|
Hematopoietic Stem Cells for Transplantation
|
3P01CA070970-09S1
|
$775,678
|
$775,678
|
CIVIN, CURT
|
JOHNS HOPKINS UNIVERSITY
|
|
CD8+ HELPER-INDEPENDENT T CELLS IN TUMOR THERAPY
|
5R01CA089511-07
|
$293,771
|
$73,443
|
COHEN, PETER
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Adoptive immunotherapy after umbilical cord blood transplant
|
1R01CA124782-01A1
|
$292,600
|
$292,600
|
COOPER, LAURENCE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
In vivo targeted DC vaccine to activate anti-tumor CTL
|
5R01CA112065-03
|
$108,340
|
$108,340
|
CUI, YAN
|
LOUISIANA STATE UNIV HSC NEW ORLEANS
|
|
Moffitt Cancer Center Support Grant
|
2P30CA076292-09
|
$2,780,246
|
$55,605
|
DALTON, WILLIAM
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Moffitt Cancer Center Support Grant
|
3P30CA076292-09S1
|
$124,501
|
$2,490
|
DALTON, WILLIAM
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Moffitt Cancer Center Support Grant
|
3P30CA076292-09S2
|
$192,356
|
$3,847
|
DALTON, WILLIAM
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Moffitt Cancer Center Support Grant
|
3P30CA076292-09S3
|
$178,221
|
$3,564
|
DALTON, WILLIAM
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Selective Therapy of Neuroblastoma
|
5R01CA079763-09
|
$213,341
|
$106,671
|
DANKS, MARY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Poor competition in hematopoietic stem/progenitor pools favors tumorigenesis
|
5R01CA109657-03
|
$214,532
|
$21,453
|
DEGREGORI, JAMES
|
UNIVERSITY OF COLORADO DENVER/HSC AURORA
|
|
Molecular & Genetic Determinants of Outcome in Breast Ca
|
5R01CA104581-04
|
$296,417
|
$148,209
|
DEMICHELE, ANGELA
|
UNIVERSITY OF PENNSYLVANIA
|
|
Mayo Comprehensive Cancer Center Grant
|
3P30CA015083-33S1
|
$110,040
|
$1,100
|
DIASIO, ROBERT
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
Mayo Comprehensive Cancer Center Grant
|
3P30CA015083-33S2
|
$98,300
|
$983
|
DIASIO, ROBERT
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
Mayo Comprehensive Cancer Center Grant
|
5P30CA015083-33
|
$5,104,634
|
$51,046
|
Diasio, Robert
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
IL-12-Faciliated Hematopoietic Recovery Following Myeloablative Therapy
|
1R41CA126005-01
|
$197,568
|
$197,568
|
DOUER, DAN
|
NEUMEDICINES, INC.
|
|
OHSU Cancer Institute
|
3P30CA069533-11S1
|
$67,584
|
$2,703
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
OHSU Cancer Institute
|
5P30CA069533-11
|
$1,133,755
|
$45,350
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Cancer Center Core Support Grant
|
3P30CA016086-32S1
|
$89,905
|
$899
|
EARP, H
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Core Support Grant
|
5P30CA016086-32
|
$6,392,142
|
$63,921
|
EARP, H
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
North American Juvenile Myelomonocytic Leukemia Project
|
5R01CA095621-05
|
$317,003
|
$158,502
|
EMANUEL, PETER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
Total relevant funding to Bone Marrow Transplantation for this search: $57,659,175
|